LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 47 filers reported holding LUMOS PHARMA INC in Q1 2020. The put-call ratio across all filers is 5.03 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $4,071,000 | 0.70% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 50,000 | $500,000 | 0.66% |
| Opaleye Management Inc. | 382,000 | $3,820,000 | 0.63% |
| Investors Financial Group, LLC | 29,600 | $296,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $178,000 | 0.09% |
| NEA Management Company, LLC | 526,663 | $5,267,000 | 0.07% |
| Marquette Asset Management, LLC | 8,919 | $89,000 | 0.02% |
| Blackstone Inc. | 468,145 | $4,681,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,543 | $522,000 | 0.01% |
| Jefferies Group LLC | 120,651 | $1,206,510 | 0.01% |